journal article·2024-07Open access

Precisely Self‐Cooperative Nanoassembly Enables Photothermal/Ferroptosis Synergistic Tumor Eradication

Xiaohong Yang, Chengcheng Feng, Pengfei Wang, Shishi Xie, Yuequan Wang, Haotian Zhang, Zhonggui He, Shenwu Zhang, Cong Luo

Advanced Healthcare Materials· Volume 13· Issue 18

Abstract

Abstract Ferroptosis is identified as a potential target for anticancer therapy. However, most conventional ferroptosis inducers not only fail to trigger intracellular lipid peroxidation storm, but are also prone to cause ferroptosis‐related toxicity through off‐target destruction of intracellular antioxidant defense systems. Therefore, a potent and highly tumor‐specific ferroptosis induction modality is desired. Herein, a self‐cooperative nanomedicine for imaging‐guided photothermal ferrotherapy, which is fabricated based on molecular nanoassembly (NA) of DiR (a photothermal probe) and ferrocene (Fc, a reactant of the Fenton reaction), is elaborately exploited. DiR‐elicited hyperthermia induces both photothermal therapy (PTT) and a significant acceleration of the kinetics of the Fc‐involved Fenton reaction, collaboratively causing a lipid peroxidation storm in tumor cells. In turn, plenty of lipid peroxides boost PTT through the downregulation of heat shock protein 90. As expected, such a self‐cooperative NA demonstrates synergetic tumor eradication in the 4T1 breast tumor‐bearing mice xenograft model. This study offers a novel nanotherapeutic paradigm for precise multimodal cancer therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Ferroptosis and cancer prognosis · Cancer, Lipids, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics Wuya College of Innovation Shenyang Pharmaceutical University Shenyang 110016 P. R. China

School of Life Science and Biopharmaceutics Shenyang Pharmaceutical University Shenyang 110016 P. R. China

Funding

National Natural Science Foundation of China

References (56)

Show source-provided references
1. 10.1016/j.apsb.2021.03.00810.1016/j.apsb.2021.03.008 ↗
2. 10.1016/j.trechm.2023.05.00610.1016/j.trechm.2023.05.006 ↗
3. 10.1016/j.cej.2022.13516010.1016/j.cej.2022.135160 ↗
4. Shan X. · J. Nanobiotechnol. · 2021 · 19
5. Sun X. · Chem. Eng. J. · 2023 · 451
6. 10.1016/j.jconrel.2019.04.00110.1016/j.jconrel.2019.04.001 ↗
7. 10.1016/j.cell.2012.03.04210.1016/j.cell.2012.03.042 ↗
8. 10.1038/cdd.2015.15810.1038/cdd.2015.158 ↗
9. 10.1038/s41419-020-2682-y10.1038/s41419-020-2682-y ↗
10. 10.1039/D3BM01153D10.1039/D3BM01153D ↗
11. Min H. · Adv. Mater. · 2020 · 32
12. 10.1016/j.cclet.2023.10819210.1016/j.cclet.2023.108192 ↗
13. 10.1002/adma.20190419710.1002/adma.201904197 ↗
14. Szatrowski T. P. · Cancer Res. · 1991 · 51 · 794
15. Zeng F. · Angew. Chem., Int. Ed. · 2022 · 61
16. b)G.Li B.Sun Y.Li C.Luo Z.He J.Sun 2021 17 2101460;10.1002/smll.202101460 ↗
17. 10.1016/j.apsb.2021.04.00510.1016/j.apsb.2021.04.005 ↗
18. 10.1021/acsami.9b0290510.1021/acsami.9b02905 ↗
19. 10.1016/j.jconrel.2020.06.03210.1016/j.jconrel.2020.06.032 ↗
20. 10.1002/adhm.20230094510.1002/adhm.202300945 ↗
21. 10.1016/j.canlet.2020.12.02810.1016/j.canlet.2020.12.028 ↗
22. 10.1002/anie.20210192410.1002/anie.202101924 ↗
23. 10.1021/acsami.1c1138110.1021/acsami.1c11381 ↗
24. He H. · Small · 2020 · 16
25. 10.1021/acsami.1c0661310.1021/acsami.1c06613 ↗
26. 10.1021/jacs.7b1202510.1021/jacs.7b12025 ↗
27. 10.1021/acsami.8b0523210.1021/acsami.8b05232 ↗
28. 10.1021/acsnano.0c0938210.1021/acsnano.0c09382 ↗
29. 10.1016/j.addr.2020.06.00510.1016/j.addr.2020.06.005 ↗
30. 10.7150/thno.3719810.7150/thno.37198 ↗
31. 10.1016/j.jconrel.2020.01.00810.1016/j.jconrel.2020.01.008 ↗
32. Alshehri S. · Pharmaceutics · 2020 · 13
33. 10.7150/thno.869810.7150/thno.8698 ↗
34. Dopierała K. · Chem. Phys. Lipids · 2023 · 250
35. 10.1007/s40005-020-00480-110.1007/s40005-020-00480-1 ↗
36. 10.1016/j.cclet.2021.11.05610.1016/j.cclet.2021.11.056 ↗
37. Zhao Z. · Biomaterials · 2020 · 255
38. Zhao Z. Q. · Adv. Sci. · 2022 · 9
39. 10.1016/j.cclet.2022.05.03210.1016/j.cclet.2022.05.032 ↗
40. Li Y. · Adv. Funct. Mater. · 2022 · 32
41. Yang G. · Adv. Healthcare Mater. · 2023 · 12
42. 10.1021/acsami.0c0664810.1021/acsami.0c06648 ↗
43. 10.1021/acs.biomac.2c0001810.1021/acs.biomac.2c00018 ↗
44. 10.1021/acsnano.0c0091010.1021/acsnano.0c00910 ↗
45. Zhang H. · Nat. Commun. · 2023 · 14
46. Li S. · Chem. Eng. J. · 2021 · 426
47. Xu G. · Chem. Eng. J. · 2021 · 414
48. 10.1021/acs.biomac.7b0177710.1021/acs.biomac.7b01777 ↗
49. Taghvaee S. · Sci. Total Environ. · 2023 · 900
50. 10.1016/j.jconrel.2017.05.00910.1016/j.jconrel.2017.05.009 ↗
51. 10.1021/acsami.2c0920910.1021/acsami.2c09209 ↗
52. Miao Y. · EBioMedicine · 2022 · 76
53. 10.1002/smm2.111910.1002/smm2.1119 ↗
54. 10.1158/1535-7163.MCT-14-045210.1158/1535-7163.MCT-14-0452 ↗
55. Zhang Y. · ACS Appl. Mater. Interfaces · 2023 · 15
56. 10.1021/acsnano.1c0038010.1021/acsnano.1c00380 ↗